ico_admin

iCo Therapeutics Inc. Agrees to a Business Combination with Satellos Bioscience Inc.

ico_admin2021-03-22T17:00:01+00:00March 22nd, 2021|2021, Press Releases|

March 15, 2021, Vancouver, Canada - iCo Therapeutics Inc. (TSXV: ICO) (OTCQB: ICOTF) (“iCo” or

ico_admin2021-03-16T00:37:52+00:00March 15th, 2021|2021, Press Releases|

March 11, 2021, Vancouver, Canada – iCo Therapeutics Inc. (TSXV: ICO) (OTCQB: ICOTF) (“iCo” or

ico_admin2021-03-12T01:01:51+00:00March 11th, 2021|2021, Press Releases|

Vancouver, British Columbia--(Newsfile Corp. - January 11, 2021) - iCo Therapeutics Inc. (TSXV: ICO) (OTCQB:

ico_admin2021-02-18T21:53:35+00:00January 11th, 2021|2021, Press Releases|

ico_admin2021-02-21T21:40:18+00:00January 1st, 2021|2021, Presentations|

ico_admin2021-02-21T21:40:49+00:00January 1st, 2021|2020, Presentations|

ico_admin2021-02-21T21:38:37+00:00January 1st, 2021|Presentations|

Vancouver, British Columbia--(Newsfile Corp. - December 31, 2020) - iCo Therapeutics (TSXV: ICO) (OTCQB: ICOTF)

ico_admin2021-02-18T21:54:27+00:00December 31st, 2020|2020, Press Releases|

ico_admin2021-02-21T21:41:08+00:00December 1st, 2020|2020, Presentations|

Vancouver, British Columbia--(Newsfile Corp. - November 24, 2020) - iCo Therapeutics (TSXV: ICO) (OTCQB: ICOTF)

ico_admin2021-02-18T21:54:33+00:00November 24th, 2020|2020, Press Releases|